IKK classic hereby announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies in the period from 01.09.2023 to 31.08.2025 for various active ingredients and combinations of active ingredients in accordance with § 130a para. 8 SGB V on the same, non-negotiable conditions. The earliest start date of the contract is 01.09.2023 (different is Lot 14 - Melatonin 1 mg and 5 mg 01.10.2023), provided that the signed contract and all necessary evidence, self-declarations and documents are received by IKK classic by 05.08.2023 (for Lot 14 - Melatonin 1 mg and 5 mg by 05.09.2023). Thereafter, the following applies: If the documents are received by the 5th of each month in the possible accession period, the 1st of the following month will be the start of the contract. If the documents are received after the 5th of each month in the possible accession period, the 1st of the month after next will be the start of the contract. Joining the agreement is possible at any time during the specified period, but no later than 05.07.2025. For further information, see point VI.3).

abatacept; ATC code: L04AA24

etravirine; ATC code: J05AG04

Immunglobuline; intravasal; ATC-Code: J06BA02

immunoglobulins; normal human, for extravascular use; ATC code: J06BA01

Indacaterol und Glycopyrroniumbromid; ATC-Code: R03AL04

latanoprost; single dose pipettes; ATC code: S01EE01

Levonorgestrel; ATC-Code: G03AD01

melatonin, 1 mg or 5 mg per extended-release tablet; Indication: Treatment of sleep disorders (insomnia) in children and adolescents aged 2-18 years with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome if sleep hygiene measures were inadequate.; ATC code: N05CH01

morphine sulfate / hydrochloride; Solution/oral solution; ATC code: N02AA01

Nilotinib; ATC code: L01EA03

palonosetron; soft capsules; ATC code: A04AA05

Atorvastatin 30 mg, 60 mg; ATC-Code: C10AA05

Peginterferon alfa-2a; ATC-Code: L03AB11

Ponesimod; ATC-Code: L04AA50

sumatriptan; solution for injection, solution for injection in a pre-filled pen, nasal spray; ATC code: N02CC01

Tacrolimus 0,03 %; Salbe; ATC-Code: D11AH01

Tamsulosin und Solifenacin; ATC-Code: G04CA53

teriflunomide; ATC code: L04AA31

tiotropium bromide; inhalation solution; ATC code: R03BB04

Trifluridin; Kombinationen; ATC-Code: L01BC59

Atovaquon; ATC-Code: P01AX06

Beclometason und Formoterol; ATC-Code: R03AK08

betamethasone and salicylic acid; Solution; ATC Code: D07XC01

Brinzolamid und Brimonidin; ATC-Code: S01EC54 (WHO); S01EC24 (ADV)

certolizumabpegol; ATC code: L04AB05

Colesevelam; ATC code: C10AC04

Dydrogesteron; ATC-Code: G03DB01